{
    "Project Title": "A Randomized, Double-Blind, Placebo-Controlled Pilot Study of an Oral, Selective Peripheral Opioid Receptor Antagonist in Advanced Non-Small Cell Lung Cancer",
    "Sponsor": "Alliance",
    "Study Number": "A221504",
    "Protocol Version and Date": "Update 2, Version Date 6/25/2019",
    "Study Title": "A Randomized, Double-Blind, Placebo-Controlled Pilot Study Of An Oral, Selective Peripheral Opioid Receptor Antagonist In Advanced Non-Small Cell Lung Cancer",
    "Phase": "Not Available",
    "Therapeutic Area": "Advanced Non-Small Cell Lung Cancer",
    "Number of Patients": "200",
    "Number of Sites": "Not Available",
    "Indication": "Advanced non-small cell lung cancer",
    "Duration of Treatment": "Up to 2 years",
    "Schedule of Assessments": "Not Available",
    "questionnaires": [
        {
            "longName": "Functional Assessment of Cancer Therapy-Lung",
            "shortName": "FACT-L",
            "type": "PRO",
            "questionnaireSchedule": "Baseline, every 3 weeks for the first year of treatment",
            "questionnaireTiming": [
                "\u2022",
                "\u2022: Prior to the start of treatment*",
                "\u2022: Every 6 weeks (+/- 7 days) until 1 year after start of treatment**",
                "\u2022: Every 3 months (+/- 7 days) from 1 year to 2 years after the start of treatment"
            ]
        },
        {
            "longName": "Patient-Reported Outcomes Common Terminology Criteria for Adverse Events",
            "shortName": "PRO-CTCAE",
            "type": "PRO",
            "questionnaireSchedule": "Every 3 weeks for the first year, then every 3 months",
            "questionnaireTiming": [
                "\u2022",
                "\u2022: Prior to the start of treatment*",
                "\u2022: Every 3 months (+/- 7 days) from 1 year to 2 years after the start of treatment"
            ]
        },
        {
            "longName": "Urinary Hesitancy Question",
            "shortName": "Urinary Hesitancy",
            "type": "PRO",
            "questionnaireSchedule": "Every 3 weeks for the first year, then every 3 months",
            "questionnaireTiming": [
                "\u2022",
                "\u2022: Prior to the start of treatment*",
                "\u2022: Every 3 months (+/- 7 days) from 1 year to 2 years after the start of treatment"
            ]
        },
        {
            "longName": "Bowel Function Diary",
            "shortName": "BF-Diary",
            "type": "PRO",
            "questionnaireSchedule": "Every 3 weeks for the first year, then every 3 months",
            "questionnaireTiming": [
                "3 and 6 weeks after start of treatment",
                "Every 6 weeks* until 1 year after start of treatment",
                "Every 3 months",
                "\u2022",
                "\u2022: Prior to the start of treatment*",
                "\u2022: Every 3 months (+/- 7 days) from 1 year to 2 years after the start of treatment"
            ]
        },
        {
            "longName": "Pain and Pain Medication Diary",
            "shortName": "Pain Diary",
            "type": "PRO",
            "questionnaireSchedule": "Every 3 weeks for the first year, then every 3 months",
            "questionnaireTiming": [
                "3 and 6 weeks after start of treatment",
                "Every 6 weeks* until 1 year after start of treatment",
                "Every 3 months",
                "\u2022",
                "\u2022: Prior to the start of treatment*",
                "\u2022: Every 3 months (+/- 7 days) from 1 year to 2 years after the start of treatment",
                "\u2022: Every 6 weeks (+/- 7 days) until 1 year after start of treatment**"
            ]
        }
    ]
}